| Ticker Symbol: | BSX |
|---|---|
| Exchange: | NYSE |
| Contact Info: | One Boston Scientific Place Natick MA 01760-1537 508 650-8000 |
| CEO/President: | James R. Tobin |
| Industry: | Medical Products / Standard Industry Code: 3841 |
| Description: | Boston Scientific Corporation is a worldwide developer, manufacturer and marketer of minimally invasive medical devices. The company\'s products are used in a broad range of interventional medical specialties, including cardiology, electrophysiology, gastroenterology, neuro-endovascular therapy, pulmonary medicine, radiology, urology and vascular surgery. |
| Shares Outstanding: | 1,500,640 (000) | Market Value: | 10,789,600 ($000) |
|---|---|---|---|
| Percentage of Inst.Shareholders: | 75.25% | Number of Inst.Shareholders: | 9.50% |
| Last Quarter Sales: | 1978.00 ($Mil.) | Last Quarter Net Income: | -62.00 ($Mil.) |
| Last Quarter EPS: | 0.16 | P/E Ratio: | 10 |
| Most Recent Earnings: | 0.16 on 10/21/08 | Earnings Per Share: | -0.06 |
| Most Recent Split: | 2-1 on 11/06/03 | Annual Dividend Rate: | 0 |
| Most Recent Dividend: | Annual Dividend Yield: | 0% |


| BOSTON SCIENTIF | -40.40 | 7.19 | |
| MEDTRONIC INC | -32.50 | 36.42 | |
| BAXTER INTL INC | -4.00 | 58.07 | |
| ZIMMER HOLDINGS | -47.30 | 39.77 | |
| ST. JUDE MEDICA | -24.30 | 31.90 |
